Please read and agree to the terms and conditions of this site.
@venturebeat.com 6 years ago
AEGEA Medical Secures $40 Million Financing
@venturebeat.com 6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com 6 years ago
Bay Labs Completes $5.5 Million Series A Financing
@venturebeat.com 6 years ago
Relay Therapeutics Secures $63 Million in Series B Financing
@venturebeat.com 6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com 6 years ago
CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function
@venturebeat.com 6 years ago
How one company learned to reinvent itself daily in the AI age
@venturebeat.com 6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com 6 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com 6 years ago
Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications
@venturebeat.com 6 years ago
Protembis Announces Successful First-in-Human Use of Its ProtEmbo® Cerebral Protection System in European Trial
@venturebeat.com 6 years ago
BrainScope Completes $16 Million Equity Fundraise
@venturebeat.com 6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com 6 years ago
Kony Announces New EASE Application to Enhance Patient Experience and Satisfaction
@venturebeat.com 6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com 6 years ago
Kony Helps Loop Rapidly Deliver New App That Connects Healthcare Providers With Patients and Their Family Members
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com 6 years ago
SpaceOAR® System Receives Shonin Approval in Japan
@venturebeat.com 7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com 7 years ago
AliveCor raises $30 million for its credit card-sized heart monitor and app
@venturebeat.com 7 years ago
Seven Bridges Announces Scientific Advisory Board
@venturebeat.com 7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com 7 years ago
Seven Bridges to Present on Cancer Moonshot’s Blood Profiling Atlas at Precision Medicine World Congress
@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com 7 years ago
MyndBlue Elects Serial Medical/Digital Health Entrepreneur Nancy Briefs
@venturebeat.com 7 years ago
Theranos lays off 41% of remaining staff
@venturebeat.com 7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com 7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30
@venturebeat.com 7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@venturebeat.com 7 years ago
National Cancer Institute Extends Scope of Seven Bridges Cancer Genomics Cloud Pilot
@venturebeat.com 7 years ago
Amazon adds 60 new Dash Buttons, including Cheez-It, Pop-Tarts, Milk Bone, and Coca-Cola
@venturebeat.com 7 years ago
HMicro Raises $10.2 Million in Series C Financing
@venturebeat.com 8 years ago
Circle Medical raises $2.9M to help promote its on-demand primary care service
@venturebeat.com 8 years ago
Portea Medical Announces US$37.5 Million Series B Funding Led by Accel
@venturebeat.com 8 years ago
Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence
@venturebeat.com 9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center
@venturebeat.com 9 years ago
NIH Awards Imbed Bio a $1.5M Grant to Develop Advanced Wound Healing Nanofilm